Related Experiment Video
Updated: Jul 8, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Resistant hypertension: challenges in everyday practice
Katarzyna Stolarz-Skrzypek1, Danuta Czarnecka2
1First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland. katarzyna.stolarz-skrzypek@uj.edu.pl
Resistant hypertension, defined as uncontrolled blood pressure despite optimal medication, affects older patients with comorbidities. Management involves assessing adherence, excluding secondary causes, and considering advanced therapies like spironolactone or device-based treatments.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Resistant hypertension is defined as blood pressure (BP) remaining above 140/90 mm Hg despite using three antihypertensive drugs, including a diuretic, at maximum doses.
- Patients with resistant hypertension are typically older and have more comorbidities than the general hypertensive population.
- Confirmation of uncontrolled hypertension requires out-of-office BP measurements, preferably 24-hour ambulatory BP monitoring.
Purpose of the Study:
- To outline the definition and diagnostic considerations for resistant hypertension.
- To emphasize the importance of optimizing pharmacotherapy and excluding contributing factors.
- To discuss advanced treatment strategies for resistant hypertension.
Main Methods:
- Reviewing the definition of resistant hypertension based on BP thresholds and medication regimens.
- Highlighting the necessity of confirming uncontrolled BP with ambulatory monitoring.
- Emphasizing the exclusion of secondary hypertension and medication nonadherence.
- Discussing the role of mineralocorticoid receptor antagonists and device-based therapies.
Main Results:
- Resistant hypertension is characterized by older age and higher comorbidity burden.
- Pseudoresistance can stem from nonadherence to medication or lifestyle recommendations.
- Optimal pharmacotherapy assessment and exclusion of drug interactions are crucial.
- Mineralocorticoid receptor antagonists (e.g., spironolactone) are recommended for expanding therapy beyond three drugs.
- Device-based treatments are an option for select patients.
Conclusions:
- Accurate diagnosis of resistant hypertension requires careful assessment of medication adherence, lifestyle factors, and exclusion of secondary causes.
- Optimizing existing therapy and considering mineralocorticoid receptor antagonists are key management steps.
- Device-based therapies offer an additional option for selected patients with resistant hypertension.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Direct Renin Inhibitors
Errors occurring during blood pressure monitoring
Several factors...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Diuretics

